A funding round has brought in $5.3 million for Lophius Biosciences, which the company aims to use to roll out its technologies. The German firm, which specializes in diagnostic tests based on T-cells, also has appointed Ralf Wagner as its managing director to help with its products' launch.

Related Summaries